Skip to main content
Premium Trial:

Request an Annual Quote

And Now, a Word from the Peanut Gallery

Continuing its grand tradition of open access, PLoS One launched a rating system for papers that promises to encourage community involvement. Here's a blog post from Chris Surridge at PLoS explaining the rating system and why it's important. And at his Tree of Life blog, Jonathan Eisen has a post on his first use of the PLoS ratings and why you should go try it out yourself.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.